Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Cyber risk research impeded by disciplinary barriers.

Falco G, Eling M, Jablanski D, Weber M, Miller V, Gordon LA, Wang SS, Schmit J, Thomas R, Elvedi M, Maillart T, Donavan E, Dejung S, Durand E, Nutter F, Scheffer U, Arazi G, Ohana G, Lin H.

Science. 2019 Nov 29;366(6469):1066-1069. doi: 10.1126/science.aaz4795. No abstract available.

PMID:
31780540
2.

A3 adenosine receptor agonist, CF102, protects against hepatic ischemia/reperfusion injury following partial hepatectomy.

Ohana G, Cohen S, Rath-Wolfson L, Fishman P.

Mol Med Rep. 2016 Nov;14(5):4335-4341. doi: 10.3892/mmr.2016.5746. Epub 2016 Sep 19.

PMID:
27666664
3.
4.

Changes in blood lipid levels following silastic ring vertical gastroplasty.

Ram E, Vishne T, Magazanik A, Harel G, Zaidman A, Ohana G, Rabinovich Y, Dreznik Z.

Obes Surg. 2007 Oct;17(10):1292-6.

PMID:
18000729
5.

Mid-term results of stapled hemorrhoidopexy for third- and fourth-degree hemorrhoids--correlation with the histological features of the resected tissue.

Ohana G, Myslovaty B, Ariche A, Dreznik Z, Koren R, Rath-Wolfson L.

World J Surg. 2007 Jun;31(6):1336-42.

PMID:
17450437
6.

Simultaneous repair of bilateral inguinal hernias: a prospective, randomized study of single versus double mesh laparoscopic totally extraperitoneal repair.

Ohana G, Powsner E, Melki Y, Estlein D, Seror D, Dreznik Z.

Surg Laparosc Endosc Percutan Tech. 2006 Feb;16(1):12-7.

PMID:
16552372
7.

Treatment of large incisional abdominal wall hernias, using a modified preperitoneal prosthetic mesh repair.

Ohana G, Bramnik Z, Miller A, Seror D, Ariche A, Bachar Gil N, Belavsky R, Dreznik Z.

Hernia. 2006 Jun;10(3):232-5. Epub 2006 Feb 2.

PMID:
16453073
8.

The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition.

Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F, Fishman P.

Clin Cancer Res. 2004 Jul 1;10(13):4472-9.

9.

Development of epidural abscess following surgical drainage of perianal abscess: report of a case.

Ohana G, Salem L, Arich A, Powzner E.

Dis Colon Rectum. 2004 Mar;47(3):392-4.

PMID:
14991504
10.

An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

Fishman P, Bar-Yehuda S, Ohana G, Barer F, Ochaion A, Erlanger A, Madi L.

Oncogene. 2004 Apr 1;23(14):2465-71.

PMID:
14691449
11.

Inguinal hernia: challenging the traditional indication for surgery in asymptomatic patients.

Ohana G, Manevwitch I, Weil R, Melki Y, Seror D, Powsner E, Dreznik Z.

Hernia. 2004 May;8(2):117-20. Epub 2003 Nov 21.

PMID:
14634843
12.

Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101.

Ohana G, Bar-Yehuda S, Arich A, Madi L, Dreznick Z, Rath-Wolfson L, Silberman D, Slosman G, Fishman P.

Br J Cancer. 2003 Oct 20;89(8):1552-8.

13.

Pancreatic sarcoidosis mimicking a malignant tumour.

Ohana G, Melki Y, Rosenblat Y, Kravarusic D, Weil R.

Eur J Surg. 2002;168(8-9):513-5. No abstract available.

PMID:
12549696
14.

Small nonpolypoid colorectal carcinoma.

Weil R, Ohana G, Halpern M, Estlein D, Avni A, Wolloch Y.

World J Surg. 2002 Apr;26(4):503-8. Epub 2002 Feb 4.

PMID:
11910488
15.

Early cancer in gastric Crohn's disease.

Estlein D, Ohana G, Weil R, Rath-Wolfson L, Wolloch Y.

Isr Med Assoc J. 2001 May;3(5):379-80. No abstract available.

16.

Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.

Ohana G, Bar-Yehuda S, Barer F, Fishman P.

J Cell Physiol. 2001 Jan;186(1):19-23. Review.

PMID:
11147810
17.

Interruptions to the physician-patient encounter: an intervention program.

Peleg R, Froimovici M, Peleg A, Milrad V, Ohana G, Fitoussi S, Dryfuss E, Sharf M, Shvartzman P.

Isr Med Assoc J. 2000 Jul;2(7):520-2.

18.

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor.

Fishman P, Bar-Yehuda S, Ohana G, Pathak S, Wasserman L, Barer F, Multani AS.

Eur J Cancer. 2000 Jul;36(11):1452-8.

PMID:
10899660
19.

The value of early and double phase 99Tcm-sestamibi scintimammography in the diagnosis of breast cancer.

Paz A, Melloul M, Cytron S, Koren R, Ohana G, Michalevich D, Gal R, Wolloch Y.

Nucl Med Commun. 2000 Apr;21(4):341-8.

PMID:
10845222
20.

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.

Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G.

J Cell Physiol. 2000 Jun;183(3):393-8.

PMID:
10797314
21.

Oral administration of muscle derived small molecules inhibits tumor spread while promoting normal cell growth in mice.

Bar-Yehuda S, Farbstein T, Barer F, Ohana G, Fishman P.

Clin Exp Metastasis. 1999;17(6):531-5.

PMID:
10763920
22.

Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer.

Melloul M, Paz A, Ohana G, Laver O, Michalevich D, Koren R, Wolloch Y, Gal R.

J Nucl Med. 1999 Mar;40(3):376-80.

23.

Comparative study of the early postoperative course and complications in patients undergoing Billroth I and Billroth II gastrectomy.

Kyzer S, Binyamini Y, Melki Y, Ohana G, Koren R, Chaimoff C, Wolloch Y.

World J Surg. 1997 Sep;21(7):763-6; discussion 767.

PMID:
9276708

Supplemental Content

Support Center